UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~June~~August 219, 2022 (August 9, 2022)

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in its charter)

Florida		0-11102		59-1564329
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

4041 SW 47 Avenue Fort Lauderdale, Florida 33314 (Address of principal executive offices, including Zip Code) (954) 587-6280 Registrant’s telephone number, including area code: Not applicable (Former name or former address, if changed since last report)

Fort Lauderdale, Florida 33314

(Address of principal executive offices, including Zip Code)

(954) 587-6280

Registrant’s telephone number, including area code:

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share		OBCI		The NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item~~Introductory ~~1.01. Entry into a Material Definitive Agreement.~~Note

~~Agreement~~As previously disclosed in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on June 22, 2022, on August 9, 2022, Ocean Bio-Chem, Inc. (the “Company”), a Florida corporation, completed its merger (the “Merger”) with OBCMS, Inc., a Florida corporation (“Merger Sub”), and a wholly owned subsidiary of OneWater Marine Inc., a Delaware corporation (“Parent”), with the Company continuing as the surviving corporation of the Merger (the “Surviving Corporation”), pursuant to the terms of the Agreement and Plan of Merger dated as of June 21, 2022 (the “Merger Agreement”), by and among the Company, Parent and Merger Sub. As a result of the Merger, the Company is now wholly owned by Parent.

~~On June~~Item ~~21, 2022, Ocean Bio-Chem, Inc~~1.,02. aTermination ~~Florida corporation (the “Company”), entered into an Agreement and Plan~~ of ~~Merger~~a ~~(the~~Material ~~“Merger~~Definitive Agreement~~”) with OneWater Marine Inc~~., a Delaware corporation (“Parent”), and OBCMS, Inc., a Florida corporation, and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which Merger Sub will be merged with and into the Company (the “Merger”) with the Company continuing as the surviving corporation (the “Surviving Corporation”) and wholly owned subsidiary of Parent following the effectiveness of the Merger.

AtThe ~~the~~information ~~effective~~set ~~time~~forth under Item 2.01 of ~~the~~this ~~Merger~~Current ~~(the~~Report ~~“Effective~~on ~~Time”):~~Form 8-K is incorporated by reference into this Item 1.02.

1.On August ~~each~~9, ~~share~~2022, ofin connection with the Merger, the Company’s ~~common~~repaid ~~stock~~in full all outstanding loans, ~~$0.01~~together ~~par~~with ~~value~~interest ~~per~~and ~~share~~all other amounts, if any, due in connection with such repayment under the (i) Credit Agreement dated July 20, 2021, between Kinpak and Regions (incorporated by reference to Exhibit 10.1 to the “Company’s ~~Common~~Quarterly ~~Stock~~Report on Form 10-Q for the quarter ended June 30, 2021) (the “Credit Agreement”); ~~that~~(ii) isGuaranty ~~owned~~Agreement dated July 20, 2021, provided by the Company to Regions (asincorporated ~~treasury~~by ~~stock~~reference orto ~~otherwise~~Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021) (the or“Guaranty ~~any~~Agreement”); ofand ~~its~~(iii) ~~direct~~Business orLoan ~~indirect~~Agreement ~~wholly~~effective ~~owned~~July ~~subsidiaries~~30, as2021, ofbetween ~~immediately~~the ~~prior~~Company and Regions (incorporated by reference to Exhibit 10.3 to the ~~Effective~~Company’s ~~Time~~Quarterly Report on Form 10-Q for the quarter ended June 30, 2021) (the “~~Cancelled~~Business ~~Shares~~Loan Agreement”) ~~will~~and ~~automatically~~together bewith ~~cancelled~~the ~~and~~Credit ~~retired~~Agreement and ~~will~~the ~~cease~~Guaranty ~~to exist~~Agreement collectively, ~~and~~the no“Loan ~~consideration~~Agreements”). ~~will~~The beLoan ~~delivered~~Agreements inwere ~~exchange;~~terminated on August 9, 2022.

Item 2.01. ~~each~~Completion ~~share~~ of ~~Company~~Acquisition ~~Common~~or ~~Stock~~Disposition ~~issued~~of ~~and outstanding immediately prior to the Effective Time (other than Cancelled Shares and Dissenting Shares as defined by the Merger Agreement) will be converted into the right to receive $13~~Assets.~~08 in cash, without interest (the “Merger Consideration”);~~

3.On August ~~all~~9, ~~shares~~2022, ofthe Company ~~Common Stock will no longer be outstanding~~ and ~~all~~Parent ~~shares~~consummated ofthe ~~Company~~transactions ~~Common~~contemplated ~~Stock~~by ~~will~~the beMerger ~~cancelled~~Agreement. ~~and~~Pursuant ~~retired and will cease~~ to ~~exist, and, subject to Section 2.03 of~~ the ~~merger agreement, each holder~~ Certificate of: ~~(i)~~Merger afiled ~~certificate~~with ~~formerly~~the ~~representing~~Secretary ~~any shares~~ of ~~Company~~State ~~Common Stock; or (ii) any book-entry shares which immediately prior to the Effective Time represented shares~~ of ~~Company Common Stock will, subject to applicable Law in~~ the ~~case~~State of ~~Dissenting Shares~~Florida, ~~cease to have any rights with respect thereto, except~~ the ~~right to receive the~~ Merger ~~Consideration~~was ineffective ~~accordance~~on ~~with~~August ~~Section~~9, ~~2.02~~2022 of (the ~~Merger Agreement; and~~“Effective Time”).

~~4. each share of common stock, par value $0.01 per share, of Merger Sub issued and outstanding immediately prior to~~ At the Effective Time shall be converted into and become one newly issued, fully paid, and non-assessable share of common stock, par value $0.01 per share, of the Surviving Corporation with the same rights, powers, and privileges as the shares so converted and shall constitute the only outstanding shares of capital stock of the Surviving Corporation. From and after the Effective Time, all certificates representing shares of Merger Sub common stock shall be deemed for all purposes to represent the number of shares of common stock of the Surviving Corporation into which they were converted in accordance with the immediately preceding sentence.:

~~Entry into~~1. ~~the~~each ~~Merger~~share ~~Agreement~~of ~~has~~the ~~been~~Company’s ~~unanimously~~common ~~approved~~stock, by$0.01 ~~the~~par ~~board~~value ofper ~~directors~~share of (the “Company, ~~based~~Common inStock”) ~~part~~that onwas owned by the ~~recommendation of~~Company a(as ~~special~~treasury ~~committee~~stock ofor ~~the~~otherwise) ~~board~~or any of ~~directors~~its ~~composed~~direct ~~entirely~~or ofindirect ~~directors~~wholly ~~who~~owned ~~are~~Subsidiaries ~~not~~as ~~parties~~of immediately prior to the ~~Merger~~Effective ~~directly~~Time or(“Cancelled ~~indirectly, other~~Shares”) ~~than~~was asautomatically acancelled ~~result~~and ofretired ~~being~~and aceased ~~shareholder~~to ~~of the Company~~exist, and ~~who have~~ no ~~direct~~consideration orwas ~~indirect material financial interest~~ or ~~other material~~will ~~interest~~be delivered in ~~the Merger.~~exchange;

~~Following execution~~2. ofeach ~~the~~share ~~Merger Agreement on June 21, 2022, holders~~ of aCompany ~~majority~~Common ofStock ~~the~~ issued and outstanding ~~shares~~immediately ofprior ~~Company~~to ~~Common Stock (~~the ~~“Consenting~~Effective ~~Shareholders”)~~Time ~~duly~~(other ~~executed~~than ~~and~~Cancelled ~~delivered~~Shares toand ~~the~~Dissenting ~~Company~~Shares ~~a written consent~~ (~~the~~as ~~“Written Consent”),~~defined ~~approving~~by ~~and adopting~~ the Merger Agreement)) ~~and~~was ~~the~~converted ~~transactions~~into ~~contemplated thereby, including~~ the ~~Merger.~~right ~~No further approval of the Company’s shareholders is required~~ to ~~adopt~~receive ~~the Merger Agreement or will be sought~~$13.08 Asin ~~a result of receipt of the Written Consent~~cash, ~~the~~without ~~Company~~interest ~~is prohibited from engaging in any further discussions or solicitations regarding an alternative potential acquisition of~~ (the ~~Company.~~“Merger Consideration”);

all shares of Company Common Stock were no longer outstanding and all shares of Company Common Stock were cancelled and retired and ceased to exist, and, subject to Section 2.03 of the Merger Agreement, each holder of: (i) a certificate formerly representing any shares of Company Common Stock; or (ii) any book-entry shares which immediately prior to the Effective Time represented shares of Company Common Stock, subject to applicable law in the case of Dissenting Shares, ceased to have any rights with respect thereto, except the right to receive the Merger Consideration in accordance with Section 2.02 of the Merger Agreement; and

~~The consummation~~4. ofeach ~~the~~share ~~Merger~~of iscommon ~~subject to customary closing conditions~~stock, ~~including~~par ~~(i)~~value ~~receiving~~$0.01 ~~the~~per ~~approval~~share, of ~~holders~~Merger ofSub aissued ~~majority of~~and ~~the~~outstanding ~~voting~~immediately ~~power~~prior ofto the ~~outstanding~~Effective ~~Company~~Time ~~Common Stock, which approval~~ was ~~effected~~converted ~~after~~into ~~execution~~and ofbecame ~~the~~one ~~Merger~~newly ~~Agreement~~issued, ~~through the~~fully ~~Written Consent~~paid, ~~(ii)~~and ~~the~~non-assessable ~~absence~~share of ~~legal~~common ~~restraints~~stock, ~~preventing~~par ~~the~~value ~~consummation~~$0.01 ofper ~~the Merger~~share, ~~(iii) the expiration or termination~~ of the ~~applicable~~Surviving ~~waiting~~Corporation ~~period~~with ~~under~~ the ~~Hart-Scott-Rodino~~same ~~Antitrust~~rights, ~~Improvements~~powers, ~~Act~~and ofprivileges ~~1976,~~ as ~~amended, (iv)~~ the ~~payoff~~shares ofso ~~certain indebtedness~~converted ~~of the Company~~ and ~~(v)~~constituted the ~~closing~~only oroutstanding ~~satisfaction~~shares ~~or waiver~~ of ~~the~~capital ~~closing~~stock ~~conditions~~ of ~~transactions~~the inSurviving ~~which (A) Peter G~~Corporation. ~~Dornau,~~From ~~the Chairman of the Board, President~~ and ~~Chief~~after ~~Executive Officer of~~ the ~~Company,~~Effective ~~and Mr. Dornau’s wife~~Time, ~~will,~~all ~~pursuant to~~certificates anrepresenting ~~equity~~shares ~~purchase agreement entered into in connection with the Merger Agreement, sell to an affiliate~~ of ~~Parent and~~ Merger Sub ~~all of the issued and outstanding shares of~~ common stock ofhave ~~Star~~been ~~Brite~~deemed ~~Europe, Inc.~~ for anall ~~aggregate~~purposes ~~purchase price of $7,000,000, subject~~ to ~~certain~~represent ~~adjustments~~the ~~and~~number ~~(B) an entity~~ of ~~which~~shares ~~Mr. Dornau is the sole managing member will, pursuant to a real estate sales contract entered into in connection with the Merger Agreement, sell to an affiliate~~ of ~~Parent~~common ~~and~~stock ~~Merger Sub certain real property, consisting~~ of the ~~Company’s~~Surviving ~~executive offices and warehouse facilities in Fort Lauderdale, Florida, for a purchase price of $3,600,000, subject to certain adjustments~~Corporation.

The ~~Merger~~foregoing ~~Agreement~~summary ~~includes~~does ~~customary~~not ~~representations,~~purport ~~warranties~~to ~~and~~be ~~covenants~~complete ~~of the Company, Parent~~ and ~~Merger~~is ~~Sub.~~qualified ~~Among~~in ~~other~~its ~~things, the~~entirety ~~Company~~by ~~has~~reference ~~agreed~~ to ~~use commercially reasonable efforts to conduct its business in~~ the ~~ordinary~~full ~~course~~text of ~~business~~the ~~consistent~~Merger ~~with~~Agreement, ~~past~~which ~~practice~~is ~~and~~included ~~use~~as ~~commercially~~Exhibit ~~reasonable~~2.1 ~~efforts~~ to ~~preserve intact its businesses until~~ the ~~Merger is consummated. The~~ Company ~~and~~’s ~~Parent~~Current ~~have~~Report ~~also~~on ~~agreed~~Form to8-K ~~use~~filed ~~their~~on ~~respective~~June ~~reasonable best efforts to obtain any approvals from governmental authorities for the Merger~~22, ~~including all required antitrust approvals~~2022, ~~on the terms~~ and ~~subject~~is toincorporated ~~the~~herein by ~~conditions set forth in the Merger Agreement~~reference.

~~The Merger~~Item ~~Agreement~~3.01. ~~contains~~Notice ~~certain provisions giving each~~ of ~~Parent~~Delisting ~~and the Company rights to terminate the Merger Agreement under certain circumstances, including the right for either Parent~~ or ~~the~~Failure ~~Company~~ to ~~terminate~~Satisfy ~~the~~a ~~Merger~~Continued ~~Agreement~~Listing ifRule ~~the Merger has not been consummated on~~ or ~~before~~Standard; ~~September~~Transfer ~~30, 2022. Upon termination~~ of ~~the Merger Agreement under specified circumstances, the Company will be required to pay Parent a termination fee of $3,375,000~~Listing. The Merger Agreement further provides that Parent will be required to pay the Company a reverse termination fee of $5,000,000 under certain circumstances if Parent is does not confirm in writing to the Company that it has available cash in an amount which, together with the Debt Financing (as defined below), is required to pay the Merger Consideration.

~~Closing~~The information set forth in Item 2.01 of ~~the~~this ~~Merger~~Current isReport ~~expected~~on toForm ~~occur~~8-K ~~during~~is ~~the~~incorporated ~~quarter~~by ~~ending~~reference ~~September~~into ~~30,~~this ~~2022~~Item 3.01.

IfAs contemplated by the Merger isAgreement, ~~consummated~~on August 9, 2022, the ~~shares~~Company notified the NASDAQ Stock Market (“NASDAQ”) of the Company’s intent to remove the Company Common Stock ~~will~~from belisting ~~delisted~~on ~~from~~NASDAQ and requested that NASDAQ file with the ~~Nasdaq~~SEC an application on Form 25 to report that the shares of Company Common Stock ~~Market~~are ~~LLC~~no ~~and~~longer ~~deregistered~~listed ~~under~~on NASDAQ. The Company intends to file a Form 15 to suspend its reporting obligations under Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended, ~~(the~~as soon ~~“Exchange~~as ~~Act”)~~practicable.

~~Also on~~Item ~~June 21, 2022, in connection with execution of the Merger Agreement, Parent entered into support agreements (the “Support Agreements”) with each of (a) Peter G~~3. Dornau, the Chairman of the Board, President and Chief Executive Officer of the Company, as well as an entity of which he is the sole managing member, in his capacity and such entity’s capacity as a shareholder of the Company, and (b) Gregor M03. ~~Dornau,~~Material ~~Executive~~Modification ~~Vice President - Sales & Marketing and a director of the Company, in his capacity as a shareholder of the Company, pursuant~~ to ~~which~~Rights ~~each such party agreed, among other things, to vote their respective beneficially owned shares~~ of ~~Company~~Security Common Stock (i) in favor of (1) the Merger Agreement and the Merger and the other transactions contemplated by the Merger Agreement, and (2) any proposal to adjourn or postpone any meeting of shareholders of the Company to a later date if there are not sufficient votes to approve the Merger; and (ii) against (1) any Takeover Proposal (including a Superior Proposal), Company Acquisition Agreement, or any of the transactions contemplated thereby (all terms as defined in the Merger Agreement), (2) any action, proposal, transaction, or agreement which could reasonably be expected to result in a breach of any covenant, representation or warranty, or any other obligation or agreement of the Company under the Merger Agreement or of such shareholder under the Support Agreement, and (3) any action, proposal, transaction, or agreement that could reasonably be expected to impede, interfere with, delay, discourage, adversely affect, or inhibit the timely consummation of the Merger or the fulfillment of Parent’s, the Company’s, or Merger Sub’s conditions under the Merger Agreement or change in any manner the voting rights of any class of shares of the Company (including any amendments to the Company’s charter documents)Holders. The Support Agreements will terminate upon the earliest to occur of (a) the Effective Time of the Merger; (b) the date on which the Merger Agreement is terminated in accordance with its terms; (c) the termination of the Support Agreement by mutual written consent of the parties hereto; or (d) any amendment or modification of, or waiver under, the Merger Agreement, in each case without the prior written consent of the shareholder party to the Support Agreement, in a manner that (i) reduces or imposes any restriction on the right of such shareholder to receive the Merger Consideration, or (ii) reduces the amount or changes the form of the Merger Consideration.

The information set forth under Items 2.01, 3.01, 5.01, and 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.

~~The foregoing~~ ~~description~~Item of5.01. ~~the~~Changes ~~Merger Agreement and the transactions contemplated thereby does not purport to be complete and is subject to and qualified~~ in ~~its~~Control ~~entirety by reference to the complete text~~ of ~~the Merger Agreement, a copy of which is attached hereto as Exhibit 2~~Registrant.1, ~~and the terms of which are incorporated herein by reference.~~

The ~~Merger Agreement has been included to provide investors and security holders with~~ information regarding its terms. It is not intended to provide any other factual information about the Company, Parent or any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Merger Agreement were made by the parties thereto only for purposes of the Merger Agreement and as of specific dates as set forth ~~therein;~~under ~~were~~Items ~~made solely for the benefit of the parties to the Merger Agreement; may be subject to limitations agreed upon by the contracting parties~~2.01, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the Merger Agreement; may have been made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors5. ~~Investors should not rely on the representations~~02, ~~warranties~~ and ~~covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Parent or Merger Sub or any of their respective subsidiaries or affiliates~~5.03 ~~Moreover, information concerning the subject matter~~ of ~~the~~this ~~representations,~~Current ~~warranties~~Report ~~and~~on ~~covenants~~Form ~~may change~~8-K ~~after~~is ~~the~~incorporated ~~date~~by ofreference ~~the~~into ~~Merger~~this ~~Agreement, which subsequent information may or may not be fully reflected in the Company’s~~Item ~~public disclosures~~5.01.

~~Item~~The 5Merger Consideration paid by Parent for the outstanding shares of Company Common Stock was approximately $13.0708 per share. ~~Submission~~The source of ~~Matters~~funds tofor the cash consideration was readily available funds. Upon the Effective Time, the Merger constituted a ~~Vote~~change of ~~Security~~control of ~~Holders~~the Company, resulting in the Company becoming a wholly owned subsidiary of Parent. There are no known arrangements which may at a subsequent date result in a change of control of the Company.

~~Following execution~~ ofItem the Merger Agreement on June 21, 2022, the Consenting Shareholders duly executed and delivered to the Company the Written Consent, approving and adopting the Merger Agreement and the transactions contemplated thereby, including the Merger5.02. NoDeparture ~~further approval~~ of ~~the~~Directors ~~Company’s shareholders is required to adopt the Merger Agreement~~ or ~~will~~Certain beOfficers; ~~sought.~~Election Asof aDirectors; ~~result~~Appointment of ~~receipt~~Certain ofOfficers; ~~the~~Compensatory ~~Written Consent,~~Agreements ~~the Company is prohibited from engaging in any further discussions or solicitations regarding an alternative potential acquisition~~ of ~~the~~Certain ~~Company~~Officers.

Pursuant to ~~rules~~the ~~adopted~~terms byof the ~~Securities~~Merger ~~and~~Agreement, ~~Exchange~~each ~~Commission~~member ~~under~~of the ~~Exchange~~board ~~Act,~~of directors of the Company ~~will~~resigned ~~prepare~~immediately ~~and~~prior ~~file~~to ~~with~~ the ~~SEC~~Effective Time, and ~~thereafter~~ ~~mail~~all toofficers ~~its~~resigned ~~stockholders,~~from aeach ~~Schedule~~of ~~14C~~their ~~Information~~respective ~~Statement~~positions as officers of the Company.

~~Item~~Following 7completion of the Merger, Philip Austin Singleton, Jr.~~01.~~ ~~Regulation~~was FDelected ~~Disclosure~~to the board of directors and to the position of President of the Company and will be the Company’s principal executive officer.

~~On June~~Item ~~22,~~5.03. ~~2022,~~Amendments ~~Parent~~to ~~and~~Articles ~~the Company issued a joint press release announcing the execution~~ of ~~the~~Incorporation ~~Merger~~or ~~Agreement.~~Bylaws; AChange ~~copy~~in ofFiscal ~~that press release is furnished as Exhibit 99~~Year.~~1 to this Current Report and incorporated herein by reference.~~

InAt ~~accordance~~the ~~with~~Effective ~~General~~Time ~~Instruction~~and ~~B.2~~pursuant ofto ~~Form 8-K,~~ the ~~foregoing~~Merger ~~information~~Agreement, ~~including Exhibit 99.1, shall not be deemed “filed” for~~ the ~~purposes~~articles of ~~Section~~incorporation 18and bylaws of the ~~Exchange~~Company ~~Act~~were oramended ~~otherwise~~and ~~subject~~ restated to ~~the~~be ~~liabilities~~in ofthe ~~that~~form ~~section,~~attached ~~nor~~hereto ~~shall~~as ~~such~~Exhibits ~~information, including Exhibit 99~~3.1, beand ~~deemed incorporated by reference into any filing under the Securities Act of 1933~~3.2, ~~as amended~~respectively, orand ~~the~~incorporated ~~Exchange Act,~~herein ~~except as shall be expressly set forth~~ by ~~specific~~ reference ~~in such filing~~.

Item 8.01. Other Events.

Financing Commitments

Parent and Truist Bank (“Truist”) have entered into a debt commitment letter, dated June 21, 2022 (the “Debt Commitment Letter”), pursuant to which Truist committed to provide Parent with debt financing in an aggregate principal amount of $125 million (the “Debt Financing”), subject to a number of conditions, including the receipt of executed loan documentation, satisfaction of the conditions to, and consummation of, the Merger and other customary closing conditions for financings of this type.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.		Description
2.1		Agreement and Plan of Merger, dated as of June 21, 2022, by and among Ocean Bio-Chem, Inc., OneWater Marine Inc. and OBCMS, Inc.+
2.1+		Agreement and Plan of Merger, dated as of June 21, 2022, by and among Ocean Bio-Chem, Inc., OneWater Marine Inc. and OBCMS, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 22, 2022).
99.1		Press Release issued by Ocean Bio-Chem, Inc. on June 22, 2022.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

3.1

Articles of Incorporation of Ocean Bio-Chem, Inc., adopted August 9, 2022.

3.2

Bylaws of Ocean Bio-Chem, Inc., adopted August 9, 2022.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

Certain schedules and exhibits to this agreement have been omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission on request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: ~~June~~August 229, 2022

OCEAN BIO-CHEM, INC.

By:	/s/ Jeffrey S. Barocas
	Name:	Jeffrey S. Barocas
	Title:	Chief Financial Officer

Filing Compare · OCEAN BIO CHEM INC